Victoria Lai
0000-0003-2918-2728
2 papers found
Refreshing results…
Tarlatamab, a First-in-Class DLL3-Targeted Bispecific T-Cell Engager, in Recurrent Small-Cell Lung Cancer: An Open-Label, Phase I Study
Signatures of plasticity, metastasis, and immunosuppression in an atlas of human small cell lung cancer
Missing publications? Search for publications with a matching author name.